Lisbon Summit Advances Serialization Supply Chain
on 07 March 2017
Event helps forge partnerships as U.S. and European pharmaceutical CMOs, CPOs and 3PLs share strategies for serialization compliance and optimize post-implementation operations.
Supply Chain Wizard, a full-service global consulting firm specializing in serialization and traceability, as well as supply chain strategy and operational transformation programs‑and Medicines for Europe, an organization serving as the voice of Europe’s generic, biosimilar and value-added medicines industries, co-hosted their latest Pharma CMO Summit June 14 in Lisbon, Portugal.
The gathering brought together manufacturers, CMOs, CPOs, 3PLs and solution providers for education and interactive activities centered on serialization compliance, serialized operations and value beyond compliance. The event presented an opportunity for pharmaceutical industry partners to make or finalize strategies for both initial compliance and optimized post-implementation operations. One of the Summit’s main goals was facilitating conversation between European pharma executives and U.S. industry experts who, in order to comply with the looming U.S. November 2017 deadline, have already prepared themselves for unit-level serialization.
With more than 80 attendees, the Lisbon event featured a variety of keynote presentations on the state of the industry, with experts sharing best practices for launching and managing serialization programs with customers and suppliers, as well as optimizing CMO-customer IT connectivity.
Detailed case studies illustrated strategies that have worked best, pitfalls that can be circumvented and roundtable discussions focused on beyond-compliance value that production digitization can bring to manufacturing operations.
The event featured more than 100 “speed-dating sessions” providing succinct networking opportunities between vendors, CMOs, 3PLs and pharma manufacturers.
Attendees represented a spectrum of functional areas within their respective organizations, and were split into a relatively equal division of executives (46%) and management (44%).
“Like its successful predecessors, the Lisbon Pharma CMO Summit brought together the full spectrum of supply chain partners,” said Evren Ozkaya, CEO of Supply Chain Wizard. “Networking exchanges were plentiful, and yielded opportunities for partnerships, collaborations and improved business practices moving beyond the need to meet regulatory requirements, into the realm of creating smarter manufacturing and supply chain operations.”